| 1 | Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospects | 7.0 | 212 | Citations (PDF) |
| 2 | Nanoparticle protein corona evolution: from biological impact to biomarker discovery | 5.0 | 53 | Citations (PDF) |
| 3 | Enhanced Competition at the Nano–Bio Interface Enables Comprehensive Characterization of Protein Corona Dynamics and Deep Coverage of Proteomes | 24.5 | 60 | Citations (PDF) |
| 4 | Analysis of the Human Plasma Proteome Using Multi‐Nanoparticle Protein Corona for Detection of Alzheimer's Disease | 8.8 | 48 | Citations (PDF) |
| 5 | Adjuvant-pulsed mRNA vaccine nanoparticle for immunoprophylactic and therapeutic tumor suppression in mice | 12.1 | 203 | Citations (PDF) |
| 6 | Nano–Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection | 17.0 | 148 | Citations (PDF) |
| 7 | Stanene‐Based Nanosheets for β‐Elemene Delivery and Ultrasound‐Mediated Combination Cancer Therapy | 1.4 | 12 | Citations (PDF) |
| 8 | Stanene‐Based Nanosheets for β‐Elemene Delivery and Ultrasound‐Mediated Combination Cancer Therapy | 14.4 | 183 | Citations (PDF) |
| 9 | Targeted delivery of protein arginine deiminase-4 inhibitors to limit arterial intimal NETosis and preserve endothelial integrity | 5.5 | 54 | Citations (PDF) |
| 10 | Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models | 12.5 | 221 | Citations (PDF) |
| 11 | Redox-responsive polyprodrug nanoparticles for targeted siRNA delivery and synergistic liver cancer therapy | 12.1 | 124 | Citations (PDF) |
| 12 | A materials-science perspective on tackling COVID-19 | 77.9 | 294 | Citations (PDF) |
| 13 | Oral Insulin Delivery Platforms: Strategies To Address the Biological Barriers | 14.4 | 154 | Citations (PDF) |
| 14 | siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice | 12.5 | 236 | Citations (PDF) |
| 15 | Rücktitelbild: Plattformen für die orale Insulinabgabe: Strategien zur Beseitigung der biologischen Barrieren (Angew. Chem. 45/2020) | 1.4 | 1 | Citations (PDF) |
| 16 | Plattformen für die orale Insulinabgabe: Strategien zur Beseitigung der biologischen Barrieren | 1.4 | 5 | Citations (PDF) |
| 17 | Dual Hypoxia-Targeting RNAi Nanomedicine for Precision Cancer Therapy | 8.7 | 62 | Citations (PDF) |
| 18 | Germanene-Based Theranostic Materials for Surgical Adjuvant Treatment: Inhibiting Tumor Recurrence and Wound Infection | 16.0 | 248 | Citations (PDF) |
| 19 | Marriage of black phosphorus and Cu2+ as effective photothermal agents for PET-guided combination cancer therapy | 13.7 | 330 | Citations (PDF) |
| 20 | Nanostructure Engineering by Simple Tuning of Lipid Combinations | 1.4 | 2 | Citations (PDF) |
| 21 | ROS-Mediated Selective Killing Effect of Black Phosphorus: Mechanistic Understanding and Its Guidance for Safe Biomedical Applications | 8.7 | 208 | Citations (PDF) |
| 22 | Phosphorus Science-Oriented Design and Synthesis of Multifunctional Nanomaterials for Biomedical Applications | 16.0 | 195 | Citations (PDF) |
| 23 | Nanostructure Engineering by Simple Tuning of Lipid Combinations | 14.4 | 24 | Citations (PDF) |
| 24 | Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy | 8.7 | 157 | Citations (PDF) |
| 25 | Sugar-Nanocapsules Imprinted with Microbial Molecular Patterns for mRNA Vaccination | 8.7 | 87 | Citations (PDF) |
| 26 | Stimuli-Responsive Polymer–Prodrug Hybrid Nanoplatform for Multistage siRNA Delivery and Combination Cancer Therapy | 8.7 | 132 | Citations (PDF) |
| 27 | 2D Monoelemental Germanene Quantum Dots: Synthesis as Robust Photothermal Agents for Photonic Cancer Nanomedicine | 1.4 | 48 | Citations (PDF) |
| 28 | 2D Monoelemental Germanene Quantum Dots: Synthesis as Robust Photothermal Agents for Photonic Cancer Nanomedicine | 14.4 | 119 | Citations (PDF) |
| 29 | Emerging two-dimensional monoelemental materials (Xenes) for biomedical applications | 37.7 | 601 | Citations (PDF) |
| 30 | Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes
p53
-deficient cancers to mTOR inhibition | 12.5 | 296 | Citations (PDF) |
| 31 | Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy | 15.3 | 262 | Citations (PDF) |
| 32 | Drug loading augmentation in polymeric nanoparticles using a coaxial turbulent jet mixer: Yong investigator perspective | 9.9 | 21 | Citations (PDF) |
| 33 | Nanotechnology-Based Strategies for siRNA Brain Delivery for Disease Therapy | 8.7 | 207 | Citations (PDF) |
| 34 | Intracellular Mechanistic Understanding of 2D MoS2 Nanosheets for Anti-Exocytosis-Enhanced Synergistic Cancer Therapy | 15.3 | 218 | Citations (PDF) |
| 35 | Engineering of Mature Human Induced Pluripotent Stem Cell‐Derived Cardiomyocytes Using Substrates with Multiscale Topography | 17.0 | 50 | Citations (PDF) |
| 36 | Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery | 11.3 | 23 | Citations (PDF) |
| 37 | Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA | 22.4 | 314 | Citations (PDF) |
| 38 | Redox‐Responsive Nanoparticle‐Mediated Systemic RNAi for Effective Cancer Therapy | 11.5 | 101 | Citations (PDF) |
| 39 | Two‐Dimensional Antimonene‐Based Photonic Nanomedicine for Cancer Theranostics | 24.5 | 340 | Citations (PDF) |
| 40 | Flat Cell Culturing Surface May Cause Misinterpretation of Cellular Uptake of Nanoparticles | 3.4 | 7 | Citations (PDF) |
| 41 | Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance | 8.7 | 199 | Citations (PDF) |
| 42 | Personalized protein corona on nanoparticles and its clinical implications | 5.7 | 283 | Citations (PDF) |
| 43 | Hyper-cell-permeable micelles as a drug delivery carrier for effective cancer therapy | 12.1 | 44 | Citations (PDF) |
| 44 | Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy | 15.3 | 197 | Citations (PDF) |
| 45 | Antimonene Quantum Dots: Synthesis and Application as Near‐Infrared Photothermal Agents for Effective Cancer Therapy | 14.4 | 509 | Citations (PDF) |
| 46 | Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi and Cancer Therapy | 8.7 | 128 | Citations (PDF) |
| 47 | Antimonene Quantum Dots: Synthesis and Application as Near‐Infrared Photothermal Agents for Effective Cancer Therapy | 1.4 | 103 | Citations (PDF) |
| 48 | Design of Insulin-Loaded Nanoparticles Enabled by Multistep Control of Nanoprecipitation and Zinc Chelation | 8.0 | 33 | Citations (PDF) |
| 49 | Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics | 13.7 | 661 | Citations (PDF) |
| 50 | Nanomedicine for safe healing of bone trauma: Opportunities and challenges | 12.1 | 78 | Citations (PDF) |
| 51 | Multiscale technologies for treatment of ischemic cardiomyopathy | 32.2 | 138 | Citations (PDF) |
| 52 | Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr−/− Mice | 8.8 | 80 | Citations (PDF) |
| 53 | ROS‐Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy | 24.5 | 477 | Citations (PDF) |
| 54 | Cellular uptake of nanoparticles: journey inside the cell | 37.7 | 2,619 | Citations (PDF) |
| 55 | Evolution of macromolecular complexity in drug delivery systems | 46.5 | 304 | Citations (PDF) |
| 56 | Innentitelbild: Antimonene Quantum Dots: Synthesis and Application as Near‐Infrared Photothermal Agents for Effective Cancer Therapy (Angew. Chem. 39/2017) | 1.4 | 2 | Citations (PDF) |
| 57 | Challenges in DNA Delivery and Recent Advances in Multifunctional Polymeric DNA Delivery Systems | 5.1 | 188 | Citations (PDF) |
| 58 | A drug-delivery strategy for overcoming drug resistance in breast cancer through targeting of oncofetal fibronectin | 3.6 | 41 | Citations (PDF) |
| 59 | Biological Identity of Nanoparticles In Vivo : Clinical Implications of the Protein Corona | 8.7 | 393 | Citations (PDF) |
| 60 | Emerging Advances in Nanotheranostics with Intelligent Bioresponsive Systems | 11.3 | 52 | Citations (PDF) |
| 61 | Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo | 11.3 | 133 | Citations (PDF) |
| 62 | Polymeric Nanoparticles Amenable to Simultaneous Installation of Exterior Targeting and Interior Therapeutic Proteins | 14.4 | 145 | Citations (PDF) |
| 63 | Ultra‐pH‐Responsive and Tumor‐Penetrating Nanoplatform for Targeted siRNA Delivery with Robust Anti‐Cancer Efficacy | 14.4 | 244 | Citations (PDF) |
| 64 | Preventing diet-induced obesity in mice by adipose tissue transformation and angiogenesis using targeted nanoparticles | 7.5 | 180 | Citations (PDF) |
| 65 | Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis | 15.3 | 212 | Citations (PDF) |
| 66 | Targeted Nanoparticles for Colorectal Cancer | 3.0 | 149 | Citations (PDF) |
| 67 | Emerging understanding of the protein corona at the nano-bio interfaces | 9.9 | 234 | Citations (PDF) |
| 68 | Nanomedicines for renal disease: current status and future applications | 32.8 | 235 | Citations (PDF) |
| 69 | Ultra‐pH‐Responsive and Tumor‐Penetrating Nanoplatform for Targeted siRNA Delivery with Robust Anti‐Cancer Efficacy | 1.4 | 10 | Citations (PDF) |
| 70 | Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer | 7.5 | 87 | Citations (PDF) |
| 71 | Polymeric Nanoparticles Amenable to Simultaneous Installation of Exterior Targeting and Interior Therapeutic Proteins | 1.4 | 11 | Citations (PDF) |
| 72 | Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release | 52.5 | 2,853 | Citations (PDF) |
| 73 | Nanotechnology for protein delivery: Overview and perspectives | 11.0 | 377 | Citations (PDF) |
| 74 | Cancer nanomedicine: progress, challenges and opportunities | 60.7 | 5,436 | Citations (PDF) |
| 75 | Hydrophobic Cysteine Poly(disulfide)‐based Redox‐Hypersensitive Nanoparticle Platform for Cancer Theranostics | 1.4 | 40 | Citations (PDF) |
| 76 | Hydrophobic Cysteine Poly(disulfide)‐based Redox‐Hypersensitive Nanoparticle Platform for Cancer Theranostics | 14.4 | 183 | Citations (PDF) |
| 77 | Drug Delivery Nanocarriers from a Fully Degradable PEG‐Conjugated Polyester with a Reduction‐Responsive Backbone | 3.4 | 26 | Citations (PDF) |
| 78 | Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice | 12.5 | 329 | Citations (PDF) |
| 79 | Effect of PEG Pairing on the Efficiency of Cancer-Targeting Liposomes | 11.3 | 76 | Citations (PDF) |
| 80 | Nanomedicines for endothelial disorders | 9.9 | 55 | Citations (PDF) |
| 81 | Cancer nanomedicine: from targeted delivery to combination therapy | 7.4 | 668 | Citations (PDF) |
| 82 | Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance | 7.5 | 432 | Citations (PDF) |
| 83 | Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment | 7.5 | 199 | Citations (PDF) |
| 84 | A mucosal vaccine against
Chlamydia trachomatis
generates two waves of protective memory T cells | 36.3 | 371 | Citations (PDF) |
| 85 | Polymeric nanoparticle drug delivery technologies for oral delivery applications | 5.0 | 249 | Citations (PDF) |
| 86 | Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug | 13.7 | 415 | Citations (PDF) |
| 87 | Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle | 12.5 | 324 | Citations (PDF) |
| 88 | Nanoparticles Containing a Liver X Receptor Agonist Inhibit Inflammation and Atherosclerosis | 8.8 | 79 | Citations (PDF) |
| 89 | Annexin A1–containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair | 10.6 | 323 | Citations (PDF) |
| 90 | Development of Therapeutic Polymeric Nanoparticles for the Resolution of Inflammation | 8.8 | 34 | Citations (PDF) |
| 91 | Ultra-High Throughput Synthesis of Nanoparticles with Homogeneous Size Distribution Using a Coaxial Turbulent Jet Mixer | 15.3 | 283 | Citations (PDF) |
| 92 | Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology | 15.4 | 2,676 | Citations (PDF) |
| 93 | Development of Multinuclear Polymeric Nanoparticles as Robust Protein Nanocarriers | 1.4 | 10 | Citations (PDF) |
| 94 | A Solvent-Free Thermosponge Nanoparticle Platform for Efficient Delivery of Labile Proteins | 8.7 | 43 | Citations (PDF) |
| 95 | Development of Multinuclear Polymeric Nanoparticles as Robust Protein Nanocarriers | 14.4 | 139 | Citations (PDF) |
| 96 | Current Progress of Aptamer-Based Molecular Imaging | 5.1 | 103 | Citations (PDF) |
| 97 | Insight into nanoparticle cellular uptake and intracellular targeting | 11.0 | 750 | Citations (PDF) |
| 98 | Polymeric Nanoparticle Technologies for Oral Drug Delivery | 6.0 | 158 | Citations (PDF) |
| 99 | Engineered nanomedicine for myeloma and bone microenvironment targeting | 7.5 | 270 | Citations (PDF) |
| 100 | Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release | 3.1 | 165 | Citations (PDF) |
| 101 | Parallel microfluidic synthesis of size-tunable polymeric nanoparticles using 3D flow focusing towards in vivo study | 3.6 | 157 | Citations (PDF) |
| 102 | Hybrid lipid–polymer nanoparticles for sustained siRNA delivery and gene silencing | 3.6 | 93 | Citations (PDF) |
| 103 | Synthesis and in vitro evaluation of a multifunctional and surface-switchable nanoemulsion platform | 3.4 | 16 | Citations (PDF) |
| 104 | Synthesis of Polymer–Lipid Nanoparticles for Image-Guided Delivery of Dual Modality Therapy | 3.8 | 111 | Citations (PDF) |
| 105 | Single Step Reconstitution of Multifunctional High-Density Lipoprotein-Derived Nanomaterials Using Microfluidics | 15.3 | 116 | Citations (PDF) |
| 106 | Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug | 7.5 | 335 | Citations (PDF) |
| 107 | Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery | 12.5 | 377 | Citations (PDF) |
| 108 | HER2-specific aptide conjugated magneto-nanoclusters for potential breast cancer imaging and therapy | 5.5 | 17 | Citations (PDF) |
| 109 | Synergistic Cytotoxicity of Irinotecan and Cisplatin in Dual-Drug Targeted Polymeric Nanoparticles | 3.0 | 70 | Citations (PDF) |
| 110 | Nanoparticle Encapsulation of Mitaplatin and the Effect Thereof onIn VivoProperties | 15.3 | 91 | Citations (PDF) |
| 111 | Microfluidic Platform for Combinatorial Synthesis and Optimization of Targeted Nanoparticles for Cancer Therapy | 15.3 | 225 | Citations (PDF) |
| 112 | Spontaneous Formation of Heterogeneous Patches on Polymer–Lipid Core–Shell Particle Surfaces during Self‐Assembly | 11.5 | 17 | Citations (PDF) |
| 113 | Nanoparticle Design For Bone-Specific Chemotherapy and Microenvironmental Targeting In Multiple MyelomaBlood, 2013, 122, 881-881 | 4.8 | 2 | Citations (PDF) |
| 114 | Nanoparticle-Aptamer Bioconjugates for Targeted Antineoplastic Drug Delivery | 0.8 | 2 | Citations (PDF) |
| 115 | Surface Charge-Switching Polymeric Nanoparticles for Bacterial Cell Wall-Targeted Delivery of Antibiotics | 15.3 | 520 | Citations (PDF) |
| 116 | Bioinspired multivalent DNA network for capture and release of cells | 7.5 | 284 | Citations (PDF) |
| 117 | Engineering of Targeted Nanoparticles for Cancer Therapy Using Internalizing Aptamers Isolated by Cell-Uptake Selection | 15.3 | 153 | Citations (PDF) |
| 118 | Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine | 15.4 | 460 | Citations (PDF) |
| 119 | DNA Self‐Assembly of Targeted Near‐Infrared‐Responsive Gold Nanoparticles for Cancer Thermo‐Chemotherapy | 1.4 | 92 | Citations (PDF) |
| 120 | DNA Self‐Assembly of Targeted Near‐Infrared‐Responsive Gold Nanoparticles for Cancer Thermo‐Chemotherapy | 14.4 | 324 | Citations (PDF) |
| 121 | Microfluidic technologies for accelerating the clinical translation of nanoparticles | 32.2 | 656 | Citations (PDF) |
| 122 | Engineering of lipid-coated PLGA nanoparticles with a tunable payload of diagnostically active nanocrystals for medical imaging | 3.4 | 90 | Citations (PDF) |
| 123 | αVβ3 Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug | 15.3 | 316 | Citations (PDF) |
| 124 | Mass Production and Size Control of Lipid–Polymer Hybrid Nanoparticles through Controlled Microvortices | 8.7 | 221 | Citations (PDF) |
| 125 | Nanoparticle Delivery of Cancer Drugs | 18.7 | 1,489 | Citations (PDF) |
| 126 | Targeted polymeric therapeutic nanoparticles: design, development and clinical translation | 37.7 | 1,665 | Citations (PDF) |
| 127 | Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile | 12.5 | 1,076 | Citations (PDF) |
| 128 | Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo | 7.5 | 503 | Citations (PDF) |
| 129 | Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation | 17.0 | 465 | Citations (PDF) |
| 130 | Advances in Drug Delivery | 9.4 | 129 | Citations (PDF) |
| 131 | Synthesis of Size‐Tunable Polymeric Nanoparticles Enabled by 3D Hydrodynamic Flow Focusing in Single‐Layer Microchannels | 24.5 | 208 | Citations (PDF) |
| 132 | Differentially Charged Hollow Core/Shell Lipid–Polymer–Lipid Hybrid Nanoparticles for Small Interfering RNA Delivery | 1.4 | 32 | Citations (PDF) |
| 133 | Differentially Charged Hollow Core/Shell Lipid–Polymer–Lipid Hybrid Nanoparticles for Small Interfering RNA Delivery | 14.4 | 181 | Citations (PDF) |
| 134 | Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles | 12.1 | 179 | Citations (PDF) |
| 135 | In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid–polymeric nanoparticles | 7.5 | 136 | Citations (PDF) |
| 136 | Emerging Nanotechnology Approaches for HIV/AIDS Treatment and Prevention | 3.0 | 230 | Citations (PDF) |
| 137 | Poly(ethylene glycol) with Observable Shedding | 1.4 | 9 | Citations (PDF) |
| 138 | Poly(ethylene glycol) with Observable Shedding | 14.4 | 69 | Citations (PDF) |
| 139 | On firm ground: IP protection of therapeutic nanoparticles | 29.8 | 79 | Citations (PDF) |
| 140 | Spatiotemporal controlled delivery of nanoparticles to injured vasculature | 7.5 | 249 | Citations (PDF) |
| 141 | Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy | 7.5 | 564 | Citations (PDF) |
| 142 | Chemorad Nanoparticles: A Novel Multifunctional Nanoparticle Platform for Targeted Delivery of Concurrent Chemoradiation | 3.0 | 102 | Citations (PDF) |
| 143 | Single-Step Assembly of Homogenous Lipid−Polymeric and Lipid−Quantum Dot Nanoparticles Enabled by Microfluidic Rapid Mixing | 15.3 | 321 | Citations (PDF) |
| 144 | pH-Responsive Nanoparticles for Drug Delivery | 4.2 | 968 | Citations (PDF) |
| 145 | Design of a mechanical clutch-based needle-insertion device | 7.5 | 14 | Citations (PDF) |
| 146 | PLGA–lecithin–PEG core–shell nanoparticles for controlled drug delivery | 12.1 | 673 | Citations (PDF) |
| 147 | Immunocompatibility properties of lipid–polymer hybrid nanoparticles with heterogeneous surface functional groups | 12.1 | 256 | Citations (PDF) |
| 148 | Multifunctional nanoparticles for prostate cancer therapy | 2.5 | 23 | Citations (PDF) |
| 149 | Superparamagnetic Iron Oxide Nanoparticle–Aptamer Bioconjugates for Combined Prostate Cancer Imaging and Therapy | 3.1 | 312 | Citations (PDF) |
| 150 | HER‐2‐Targeted Nanoparticle–Affibody Bioconjugates for Cancer Therapy | 3.1 | 155 | Citations (PDF) |
| 151 | The use of charge-coupled polymeric microparticles and micromagnets for modulating the bioavailability of orally delivered macromolecules | 12.1 | 66 | Citations (PDF) |
| 152 | Nanotechnology and aptamers: applications in drug delivery | 8.7 | 269 | Citations (PDF) |
| 153 | New frontiers in nanotechnology for cancer treatment | 1.8 | 303 | Citations (PDF) |
| 154 | Microfluidic Platform for Controlled Synthesis of Polymeric Nanoparticles | 8.7 | 846 | Citations (PDF) |
| 155 | Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform | 15.3 | 985 | Citations (PDF) |
| 156 | Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles | 4.2 | 3,400 | Citations (PDF) |
| 157 | Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers | 7.5 | 690 | Citations (PDF) |
| 158 | Nanofabrication and Microfabrication of Functional Materials for Tissue Engineering | 4.8 | 118 | Citations (PDF) |
| 159 | Biodegradable, Polymeric Nanoparticle Delivery Systems for Cancer Therapy | 3.0 | 227 | Citations (PDF) |
| 160 | Co-Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle–Aptamer Bioconjugates | 3.1 | 257 | Citations (PDF) |
| 161 | Targeted nanoparticles for cancer therapy | 9.9 | 466 | Citations (PDF) |
| 162 | Nanocarriers as an emerging platform for cancer therapy | 32.2 | 8,269 | Citations (PDF) |
| 163 | Quantum Dot−Aptamer Conjugates for Synchronous Cancer Imaging, Therapy, and Sensing of Drug Delivery Based on Bi-Fluorescence Resonance Energy Transfer | 8.7 | 1,004 | Citations (PDF) |
| 164 | Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery | 12.1 | 1,243 | Citations (PDF) |
| 165 | Drug delivery systems in urology—getting “smarter” | 1.4 | 31 | Citations (PDF) |
| 166 | Micropatterned cell co-cultures using layer-by-layer deposition of extracellular matrix components | 12.1 | 224 | Citations (PDF) |
| 167 | Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy
in vivo | 7.5 | 1,679 | Citations (PDF) |
| 168 | Nanoparticle–aptamer bioconjugates for cancer targeting | 5.0 | 257 | Citations (PDF) |
| 169 | Magnetically Responsive Polymeric Microparticles for Oral Delivery of Protein Drugs | 3.7 | 128 | Citations (PDF) |
| 170 | An Aptamer–Doxorubicin Physical Conjugate as a Novel Targeted Drug-Delivery Platform | 14.4 | 596 | Citations (PDF) |
| 171 | Microfluidic System for Studying the Interaction of Nanoparticles and Microparticles with Cells | 6.5 | 168 | Citations (PDF) |
| 172 | Cell docking inside microwells within reversibly sealed microfluidic channels for fabricating multiphenotype cell arrays | 5.1 | 227 | Citations (PDF) |
| 173 | Nanoparticle-Aptamer Bioconjugates | 3.8 | 909 | Citations (PDF) |
| 174 | CD11c gene expression in hairy cell leukemia is dependent upon activation of the proto-oncogenes ras andjunDBlood, 2003, 101, 4033-4041 | 4.8 | 43 | Citations (PDF) |
| 175 | Regulation of epithelial transport and barrier function by distinct protein kinase C isoforms | 4.2 | 83 | Citations (PDF) |
| 176 | CD43 gene expression is mediated by a nuclear factor which binds pyrimidine-rich single-stranded DNA | 15.5 | 14 | Citations (PDF) |
| 177 | Differential effects of PKC isoforms on epithelial transport and barrier function | 0.9 | 0 | Citations (PDF) |
| 178 | Effects of bryostatin 1, a novel anticancer agent, on intestinal transport and barrier function: Role of protein kinase C | 1.8 | 16 | Citations (PDF) |
| 179 | Levamisole inhibits intestinal Cl− secretion via basolateral K+ channel blockade | 0.9 | 32 | Citations (PDF) |
| 180 | Effects of bryostatin 1, a novel anticancer agent, on intestinal transport and barrier function: Role of protein kinase C | 1.8 | 0 | Citations (PDF) |
| 181 | The Human β2 Integrin CD18 promoter consists of Two Inverted Ets
cis
Elements | 2.5 | 24 | Citations (PDF) |
